T. Kubo et al., Lack of evidence for peripheral alpha(1)-adrenoceptor blockade during long-term treatment of heart failure with carvedilol, J AM COL C, 38(5), 2001, pp. 1463-1469
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES The purpose of this stud), was to determine whether carvedilol's
alpha(1)-adrenoceptor antagonism persists during long-term therapy of pati
ents with congestive heart failure (CHF).
BACKGROUND Carvedilol and metoprolol differ in that carvedilol also antagon
izes beta(2)- and alpha(1)-adrenoceptors. We hypothesized that in contrast
to metoprolol, carvedilol would increase calf vascular conductance (CVC), b
lunt neurally mediated vasoconstriction and attenuate neuroeffector transfe
r function gain.
METHODS We randomized 36 patients with CHF (aged 55 +/- 1 years, ejection f
raction 19 +/- 1%, means +/- SE) to either drug. Blood pressure (BP), heart
rate, muscle sympathetic nerve activity (MSNA) and CVC were assessed befor
e and after four months of treatment. The variability of BP and MSNA was de
termined using fast Fourier transformation.
RESULTS Paired data were obtained in 23 (carvedilol, 13; metoprolol, 10) su
bjects. Both beta-blockers decreased heart rate, but neither affected mean
BP or CVC (carvedilol: 0.016 +/- 0.002 to 0.018 +/- 0.003 U; metoprolol: 0.
020 +/- 0.002 to 0.020 +/- 0.004 U). Isometric handgrip exercise (30% of ma
ximum) increased heart rate, mean BP and MSNA. The calf vasoconstrictor res
ponse to handgrip exercise was not affected by carvedilol (from 16 +/- 6 re
sistance U to 25 +/- 10 resistance U, NS). The gain of the transfer of osci
llations in MSNA into BP under resting conditions was not attenuated by car
vedilol.
CONCLUSIONS Carvedilol did not increase CVC, blunt the calf vasoconstrictor
response to handgrip or attenuate the gain of the neuroeffector transfer f
unction, indicating the absence of functionally important peripheral alpha(
1)-adrenoceptor antagonism during long-term treatment of CHF. (J Am Coll Ca
rdiol 2001;38:1463-9) (C) 2001 by the American College of Cardiology.